IC

Inge Thoger Christensen

HP High Point Pharmaceuticals: 4 patents #18 of 57Top 35%
NA Novo Nordisk A/S: 3 patents #460 of 1,775Top 30%
NA Novo Nordick A/S: 1 patents #1 of 21Top 5%
NN Novo Nordisk: 1 patents #8 of 42Top 20%
Overall (All Time): #576,916 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
8772285 Benzothiazoles having histamine H3 receptor activity Florencio Zaragoza Dorwald, Rolf Hohlweg, Jane Marie Lundbeck, Knud Erik Andersen 2014-07-08
8394842 Benzothiazoles having histamine H3 receptor activity Florencio Zaragoza Dorwald, Rolf Hohlweg, Jane Marie Lundbeck, Knud Erik Andersen 2013-03-12
7723323 Pharmaceutical use of fused 1,2,4-triazoles Henrik Sune Andersen, Gita Camilla Tejlgaard Kampen, John Patrick Mogensen, Annette Rosendal Larsen 2010-05-25
7700583 11β-hydroxysteroid dehydrogenase type 1 active compounds Anette Gundertofte, Anker Steen Jorgensen, Gita Camilla Tejlgaard Kampen, Henrik Sune Andersen, Kilburn Paul John 2010-04-20
7358238 Pharmaceutical use of fused 1,2,4-triazoles Henrik Sune Andersen, Gita Camilla Tejlgaard Kampen, John Patrick Mogensen, Annette Rosendal Larsen 2008-04-15
6953812 Glucagon antagonists/inverse agonists Anker Steen Jorgensen, Janos Tibor Kodra, Christian Sams, Carsten Behrens, Peter Madsen +1 more 2005-10-11
6881746 Glucagon antagonists/inverse agonists Jesper Lau, Peter Madsen, Paw Bloch, Carsten Behrens, Janos Tibor Kodra +1 more 2005-04-19
6762318 Glucagon antagonists Janos Tibor Kodra, Peter Madsen, Jesper Lau, Anker Steen Jorgensen 2004-07-13
6562807 Glucagon antagonists/inverse agonists Anker Steen Jorgensen, Janos Tibor Kodra, Christian Sams, Carsten Behrens, Peter Madsen +1 more 2003-05-13